A novel gene signature to predict immune infiltration and outcome in patients with prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel gene signature to predict immune infiltration and outcome in patients with prostate cancer

Published:2020-01-01 Issue:1 Volume:9 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Shao Ning¹²,Tang Hong³,Mi Yuanyuan⁴,Zhu Yao¹²,Wan Fangning¹²,Ye Dingwei¹²

Affiliation:

1. Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China

2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

3. Department of Pathology, The Affiliated WuXi No.2 People’s Hospital of Nanjing Medical University, Wuxi, China

4. Department of Urology, Affiliated Hospital of Jiangnan University, Wuxi, China

Funder

National Natural Science Foundation of China

Shanghai Rising star Program

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1762473

Reference29 articles.

1. Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study

2. Immunotherapy and endothelin receptor antagonists for treatment of castration-resistant prostate cancer

3. Risk stratification in prostate cancer screening

4. Molecular Signature to Risk-Stratify Prostate Cancer of Intermediate Risk

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AIEgen-deep: Deep learning of single AIEgen-imaging pattern for cancer cell discrimination and preclinical diagnosis;Biosensors and Bioelectronics;2024-06

2. Combined SNPs sequencing and allele specific proteomics capture reveal functional causality underpinning the 2p25 prostate cancer susceptibility locus;2024-04-04

3. Utilizing a novel model of PANoptosis-related genes for enhanced prognosis and immune status prediction in kidney renal clear cell carcinoma;Apoptosis;2024-01-28

4. The 15-year national trends of urinary cancers incidence among Iranian men and women; 2005–2020;International Journal for Equity in Health;2024-01-22

5. An endoplasmic reticulum stress-related signature featuring ASNS for predicting prognosis and immune landscape in prostate cancer;Aging;2024-01-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3